Latest Singapore News

Clever Culture Systems has started FY27 with three APAS Independence sales to Novo Nordisk and AstraZeneca, while targeting eight first-half sales and evaluations. The sales momentum comes with $1.6 million of unsecured loans due in December and a proposed extension still to be secured.

GreenX Metals is moving Tannenberg toward a planned 2027 drilling campaign while completing fieldwork across its expanded Greenland portfolio. The company is also preparing enforcement action over a Poland arbitration award, although key legal decisions remain pending.

Hydrix reported September-quarter revenue growth of 11.6% year on year and secured further medical and Defence milestones. But with $1.5 million in cash and reported funding covering only 1.30 quarters, the company still needs contract wins to convert into receipts and revenue.

Me Today says more than 80% of its Series 1 warrants have been exercised, delivering $2.31 million of new capital as the nutraceuticals company forecasts stronger first-half FY27 revenue. FY26 gross revenue rose 36% to $7.96 million while the EBITDA loss narrowed substantially.

EAU Lithium has deepened its technical relationship with Vulcan Energy Resources while the licensed VULSORB technology moves into commercial-scale manufacturing in Germany. The company ended September with A$2.621 million in cash, but its Bolivia strategy remains subject to negotiations and approvals.

Bubs Australia has expanded its US footprint to more than 12,000 stores after securing permanent FDA authorisation, but quarterly revenue fell 9.8% and operating cash outflow increased. The company ended September with A$13.4 million of available liquidity, equivalent to 2.2 quarters at the reported cash-burn rate.

Singapore-based Navaa Holdings has agreed to invest an initial $3 million in WasteCo, with a further $6.07 million potentially giving it 50.1% of the voting rights. The larger investment still depends on due diligence and shareholder approval.

Ocean Sciences has committed A$100,000 to a 12-month research program testing whether Sargassum-derived alginate can recover gold, silver and potentially rare earth elements from retired data centre hardware. The project gives the seaweed company a new industrial angle, but remains firmly at the laboratory stage.

Clever Culture Systems has fully invoiced three APAS Independence sales in the first quarter of FY27 and expects customer commitments to lift first-half sales and evaluations to eight instruments. A new paid evaluation with a Top-20 pharmaceutical company could expand its base of major drugmakers to nine, although several milestones remain prospective.

Hydrix reported stronger contract momentum and launched a defence strategy in FY26, but revenue fell, cash burn increased and its statutory loss widened to $6.72 million. The auditor identified a material uncertainty over the company’s ability to continue as a going concern, despite a $5.2 million capital raising and planned debt conversions.

Island Pharmaceuticals has secured approvals to use Galidesivir in Uganda’s Bundibugyo Ebola outbreak while advancing two complementary Marburg studies and expanding manufacturing. The progress comes with a sharper funding question: cash fell to A$7.83 million after quarterly operating outflows of A$4.93 million, leaving an estimated 1.6 quarters of funding.

MEC Resources ended the September quarter with $1.275 million in cash and reported an estimated 11.9 quarters of funding at its current operating cash burn. But its key Advent Energy investment faces a live Federal Court appeal over PEP11, while an onshore subsidiary holding the Weaber Gas Field remains in voluntary administration.